1. Norway Cardiovascular Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 350
Price: Single User License – US$2500
Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018
Summary
Global Markets Direct’s new report, “Norway Cardiovascular Devices Investment Opportunities,
Analysis and Forecasts to 2018” provides key market data on the Norway Cardiovascular Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within ten market categories – Cardiac Rhythm Management,
Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves,
Electrophysiology, Cardiovascular Surgery, External Defibrillators, Cardiac Assist Devices,
Cardiovascular Monitoring and Diagnostic Devices and Cardiovascular Prosthetic Devices. The
report also provides company shares and distribution shares data for each of the aforementioned
market categories. The report is supplemented with global corporate-level profiles of the key
market participants with information on company financials and pipeline products, wherever
available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Cardiovascular Devices market categories – Cardiac
Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart
Valves, Electrophysiology, Cardiovascular Surgery, External Defibrillators, Cardiac Assist Devices,
Cardiovascular Monitoring and Diagnostic Devices and Cardiovascular Prosthetic Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within ten market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the ten market categories.

2. - Global corporate-level profiles of key companies operating within the Norway Cardiovascular
Devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation , St. Jude Medical,
Inc., Abbott Laboratories , Cordis Corporation , Edwards Lifesciences Corporation and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Norway Cardiovascular
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195359-norway-cardiovascular-devices-investment-opportunities-analysis-
and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 14
2 Introduction 19
2.1 What is This Report About? 19
3 Cardiovascular Devices In Norway 20
3.1 Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 20
3.2 Cardiovascular Devices, Norway, Company Share (2010-2011) 26
4 Cardiac Assist Devices In Norway 28
4.1 Cardiac Assist Devices Overall Revenue, (2004-2018) 28
4.1.1 Intra-Aortic Balloon Pumps, Revenue (2004-2018) 32
4.1.2 Ventricular Assist Devices, Revenue (2004-2018) 36
4.2 Cardiac Assist Devices Overall Volume (2004-2018) 40
4.2.1 Intra-Aortic Balloon Pumps, Volume (2004-2018) 42
4.2.2 Ventricular Assist Devices, Volume (2004-2018) 46
4.3 Cardiac Assist Devices Average Price (2004-2018) 50
4.4 Cardiac Assist Devices Distribution Share (2010-2011) 51
4.5 Cardiac Assist Devices, Norway, Company Share (2010-2011) 52
5 Cardiac Rhythm Management In Norway 54
5.1 Cardiac Rhythm Management Overall Revenue, (2004-2018) 54

3. 5.1.1 Cardiac Resynchronisation Therapy, Revenue (2004-2018) 58
5.1.2 Implantable Cardioverter Defibrillators, Revenue (2004-2018) 62
5.1.3 Pacemakers, Revenue (2004-2018) 66
5.2 Cardiac Rhythm Management Overall Volume (2004-2018) 70
5.2.1 Cardiac Resynchronisation Therapy, Volume (2004-2018) 74
5.2.2 Implantable Cardioverter Defibrillators, Volume (2004-2018) 78
5.2.3 Pacemakers, Volume (2004-2018) 82
5.3 Cardiac Rhythm Management Average Price (2004-2018) 85
5.4 Cardiac Rhythm Management Distribution Share (2010-2011) 87
5.5 Cardiac Rhythm Management, Norway, Company Share (2010-2011) 88
6 Cardiovascular Monitoring and Diagnostic Devices In Norway 90
6.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue, (2004-2018) 90
6.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2004-2018) 94
6.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2004-2018) 98
6.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2010-2011) 99
6.5 Cardiovascular Monitoring and Diagnostic Devices, Norway, Company Share (2010-2011) 100
7 Cardiovascular Prosthetic Devices In Norway 102
7.1 Cardiovascular Prosthetic Devices Overall Revenue, (2004-2018) 102
7.1.1 Septal Occluders, Revenue (2004-2018) 106
7.2 Cardiovascular Prosthetic Devices Overall Volume (2004-2018) 110
7.2.1 Septal Occluders, Volume (2004-2018) 114
7.3 Cardiovascular Prosthetic Devices Average Price (2004-2018) 118
7.4 Cardiovascular Prosthetic Devices Distribution Share (2010-2011) 119
7.5 Cardiovascular Prosthetic Devices, Norway, Company Share (2010-2011) 120
8 Cardiovascular Surgery In Norway 122
8.1 Cardiovascular Surgery Overall Revenue, (2004-2018) 122
8.1.1 Beating Heart Surgery Systems, Revenue (2004-2018) 126
8.1.2 Perfusion Disposables, Revenue (2004-2018) 130
8.2 Cardiovascular Surgery Overall Volume (2004-2018) 134
8.2.1 Beating Heart Surgery Systems, Volume (2004-2018) 138
8.2.2 Perfusion Disposables, Volume (2004-2018) 142
8.3 Cardiovascular Surgery Average Price (2004-2018) 145
8.4 Cardiovascular Surgery Distribution Share (2010-2011) 146
8.5 Cardiovascular Surgery, Norway, Company Share (2010-2011) 147
9 Electrophysiology In Norway 149
9.1 Electrophysiology Overall Revenue, (2004-2018) 149
9.1.1 Electrophysiology Diagnostic Catheters, Revenue (2004-2018) 153
9.1.2 Electrophysiology Ablation Catheters, Revenue (2004-2018) 157
9.2 Electrophysiology Overall Volume (2004-2018) 161
9.2.1 Electrophysiology Diagnostic Catheters, Volume (2004-2018) 164
9.2.2 Electrophysiology Ablation Catheters, Volume (2004-2018) 168
9.3 Electrophysiology Average Price (2004-2018) 172

4. 9.4 Electrophysiology Distribution Share (2010-2011) 173
9.5 Electrophysiology, Norway, Company Share (2010-2011) 174
10 External Defibrillators In Norway 176
10.1 External Defibrillators Overall Revenue, (2004-2018) 176
10.2 External Defibrillators Overall Volume (2004-2018) 180
10.3 External Defibrillators Average Price (2004-2018) 184
10.4 External Defibrillators Distribution Share (2010-2011) 185
10.5 External Defibrillators, Norway, Company Share (2010-2011) 186
11 Interventional Cardiology In Norway 188
11.1 Interventional Cardiology Overall Revenue, (2004-2018) 188
11.1.1 Cardiac Catheters, Revenue (2004-2018) 192
11.1.2 Coronary Stents, Revenue (2004-2018) 196
11.1.3 PTCA Balloons, Revenue (2004-2018) 200
11.1.4 Arteriotomy Closure Devices, Revenue (2004-2018) 204
11.1.5 Intravascular Ultrasound Systems (IVUS), Revenue (2004-2018) 208
11.2 Interventional Cardiology Overall Volume (2004-2018) 212
11.2.1 Cardiac Catheters, Volume (2004-2018) 216
11.2.2 Coronary Stents, Volume (2004-2018) 219
11.2.3 PTCA Balloons, Volume (2004-2018) 222
11.2.4 Arteriotomy Closure Devices, Volume (2004-2018) 226
11.2.5 Intravascular Ultrasound Systems (IVUS), Volume (2004-2018) 230
11.3 Interventional Cardiology Average Price (2004-2018) 234
11.4 Interventional Cardiology Distribution Share (2010-2011) 236
11.5 Interventional Cardiology, Norway, Company Share (2010-2011) 237
12 Peripheral Vascular Devices In Norway 239
12.1 Peripheral Vascular Devices Overall Revenue, (2004-2018) 239
12.1.1 Stent Grafts, Revenue (2004-2018) 243
12.1.2 Inferior Vena Cava Filters (IVCF), Revenue (2004-2018) 247
12.1.3 Peripheral Guidewires, Revenue (2004-2018) 251
12.1.4 Peripheral Vascular Stents, Revenue (2004-2018) 255
12.1.5 Peripheral Embolic Protection Devices, Revenue (2004-2018) 259
12.2 Peripheral Vascular Devices Overall Volume (2004-2018) 263
12.2.1 Stent Grafts, Volume (2004-2018) 267
12.2.2 Inferior Vena Cava Filters (IVCF), Volume (2004-2018) 270
12.2.3 Peripheral Guidewires, Volume (2004-2018) 274
12.2.4 Peripheral Vascular Stents, Volume (2004-2018) 278
12.2.5 Peripheral Embolic Protection Devices, Volume (2004-2018) 282
12.3 Peripheral Vascular Devices Average Price (2004-2018) 286
12.4 Peripheral Vascular Devices Distribution Share (2010-2011) 288
12.5 Peripheral Vascular Devices, Norway, Company Share (2010-2011) 289
13 Prosthetic Heart Valves In Norway 291
13.1 Prosthetic Heart Valves Overall Revenue, (2004-2018) 291

5. 13.1.1 Mechanical Heart Valves, Revenue (2004-2018) 295
13.1.2 Tissue Heart Valves, Revenue (2004-2018) 299
13.2 Prosthetic Heart Valves Overall Volume (2004-2018) 303
13.2.1 Mechanical Heart Valves, Volume (2004-2018) 305
13.2.2 Tissue Heart Valves, Volume (2004-2018) 309
13.3 Prosthetic Heart Valves Average Price (2004-2018) 313
13.4 Prosthetic Heart Valves Distribution Share (2010-2011) 314
13.5 Prosthetic Heart Valves, Norway, Company Share (2010-2011) 315
14 Overview of Key Companies in Norway Cardiovascular Devices Market 317
14.1 Medtronic, Inc. 317
14.1.1 Company Overview 317
14.2 Boston Scientific Corporation 317
14.2.1 Company Overview 317
14.3 St. Jude Medical, Inc. 318
14.3.1 Company Overview 318
14.4 Cordis Corporation 318
14.4.1 Company Overview 318
14.5 Abbott Laboratories 319
14.5.1 Company Overview 319
14.6 Edwards Lifesciences Corporation 319
14.6.1 Company Overview 319
14.7 Sorin S.p.A. 320
14.7.1 Company Overview 320
14.8 Biotronik SE & Co. KG 320
14.8.1 Company Overview 320
14.9 C. R. Bard, Inc. 321
14.9.1 Company Overview 321
14.10 Terumo Corporation 321
14.10.1 Company Overview 321
14.11 Biosense Webster, Inc. 322
14.11.1 Company Overview 322
14.12 Philips Healthcare 322
14.12.1 Company Overview 322
14.13 MAQUET GmbH & Co. KG 322
14.13.1 Company Overview 322
14.14 AGA Medical Holdings, Inc. 323
14.14.1 Company Overview 323
14.15 Zoll Medical Corporation 323
14.15.1 Company Overview 323
14.16 Biosensors International Group, Ltd. 324
14.16.1 Company Overview 324
14.17 Thoratec Corporation 324

6. 14.17.1 Company Overview 324
14.18 GE Healthcare 325
14.18.1 Company Overview 325
14.19 ev3 Inc. 325
14.19.1 Company Overview 325
14.20 Volcano Corporation 326
14.20.1 Company Overview 326
14.21 Berlin Heart GmbH 326
14.21.1 Company Overview 326
14.22 HeartWare International, Inc. 326
14.22.1 Company Overview 326
14.23 Cardiac Science Corporation 327
14.23.1 Company Overview 327
14.24 Teleflex Incorporated 327
14.24.1 Company Overview 327
14.25 Welch Allyn Inc. 328
14.25.1 Company Overview 328
14.26 Nihon Kohden Corporation 328
14.26.1 Company Overview 328
14.27 Schiller AG 329
14.27.1 Company Overview 329
14.28 B. Braun Melsungen AG 329
14.28.1 Company Overview 329
14.29 W. L. Gore & Associates, Inc. 330
14.29.1 Company Overview 330
14.30 Fukuda Denshi Co., Ltd. 330
14.30.1 Company Overview 330
14.31 OSI Systems, Inc. 330
14.31.1 Company Overview 330
14.32 Opto Circuits India Limited 331
14.32.1 Company Overview 331
14.33 CareFusion Corporation 331
14.33.1 Company Overview 331
14.34 Covidien plc 332
14.34.1 Company Overview 332
15 Appendix 333
15.1 Global Markets Direct Research Methodology 333
15.2 Definitions of Markets Covered in the Report 334
15.2.1 Cardiovascular Devices 334
15.3 Secondary Research 348
15.4 Primary Research 348
15.5 Models 349

7. 15.6 Forecasts 349
15.7 Expert Panel Validation 349
15.8 Currency Conversion 350
15.9 Contact Us 350
15.10 Disclaimer 350
1.1 List of Tables
Table 1: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 21
Table 2: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 23
Table 3: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 25
Table 4: Cardiovascular Devices, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 27
Table 5: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 29
Table 6: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 31
Table 7: Intra-Aortic Balloon Pumps, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Historic, 2004-2011 33
Table 8: Intra-Aortic Balloon Pumps, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Forecast, 2011-2018 35
Table 9: Ventricular Assist Devices, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Historic, 2004-2011 37
Table 10: Ventricular Assist Devices, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Forecast, 2011-2018 39
Table 11: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011 40
Table 12: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Forecast, 2011-2018 41
Table 13: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 43
Table 14: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 45
Table 15: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 47
Table 16: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 49
Table 17: Cardiac Assist Devices, Norway, Average Price ($), Historic, 2004-2011 50
Table 18: Cardiac Assist Devices, Norway, Average Price ($), Forecast, 2011-2018 50
Table 19: Cardiac Assist Devices, Norway, Distribution Share by Revenue ($m), USD Constant,
2010-2011 51
Table 20: Cardiac Assist Devices, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 53

8. Table 21: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 55
Table 22: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 57
Table 23: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 59
Table 24: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 61
Table 25: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 63
Table 26: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 65
Table 27: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 67
Table 28: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 69
Table 29: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Historic, 2004-
2011 71
Table 30: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Forecast, 2011-
2018 73
Table 31: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment, Historic,
2004-2011 75
Table 32: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 77
Table 33: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 79
Table 34: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 81
Table 35: Pacemakers, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 83
Table 36: Pacemakers, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 84
Table 37: Cardiac Rhythm Management, Norway, Average Price ($), Historic, 2004-2011 85
Table 38: Cardiac Rhythm Management, Norway, Average Price ($), Forecast, 2011-2018 86
Table 39: Cardiac Rhythm Management, Norway, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 87
Table 40: Cardiac Rhythm Management, Norway, Company Share by Revenue ($m), USD
Constant, 2010-2011 89
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m*) USD
Constant, by Segment, Historic, 2004-2011 91
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m*) USD
Constant, by Segment, Forecast, 2011-2018 93
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) by
Segment, Historic, 2004-2011 95

9. Table 44: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) by
Segment, Forecast, 2011-2018 97
Table 45: Cardiovascular Monitoring and Diagnostic Devices, Norway, Average Price ($), Historic,
2004-2011 98
Table 46: Cardiovascular Monitoring and Diagnostic Devices, Norway, Average Price ($),
Forecast, 2011-2018 98
Table 47: Cardiovascular Monitoring and Diagnostic Devices, Norway, Distribution Share by
Revenue ($m), USD Constant, 2010-2011 99
Table 48: Cardiovascular Monitoring and Diagnostic Devices, Norway, Company Share by
Revenue ($m), USD Constant, 2010-2011 101
Table 49: Cardiovascular Prosthetic Devices, Norway, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 103
Table 50: Cardiovascular Prosthetic Devices, Norway, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 105
Table 51: Septal Occluders, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 107
Table 52: Septal Occluders, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 109
Table 53: Cardiovascular Prosthetic Devices, Norway, Volume (Units) by Segment, Historic, 2004-
2011 111
Table 54: Cardiovascular Prosthetic Devices, Norway, Volume (Units) by Segment, Forecast,
2011-2018 113
Table 55: Septal Occluders, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 115
Table 56: Septal Occluders, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 117
Table 57: Cardiovascular Prosthetic Devices, Norway, Average Price ($), Historic, 2004-2011 118
Table 58: Cardiovascular Prosthetic Devices, Norway, Average Price ($), Forecast, 2011-2018
118
Table 59: Cardiovascular Prosthetic Devices, Norway, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 119
Table 60: Cardiovascular Prosthetic Devices, Norway, Company Share by Revenue ($m), USD
Constant, 2010-2011 121
Table 61: Cardiovascular Surgery, Norway, Revenue ($m*) USD Constant, by Segment, Historic,
2004-2011 123
Table 62: Cardiovascular Surgery, Norway, Revenue ($m*) USD Constant, by Segment, Forecast,
2011-2018 125
Table 63: Beating Heart Surgery Systems, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 127
Table 64: Beating Heart Surgery Systems, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 129
Table 65: Perfusion Disposables, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 131
Table 66: Perfusion Disposables, Norway, Revenue ($m) USD Constant, by Sub-Segment,

10. Forecast, 2011-2018 133
Table 67: Cardiovascular Surgery, Norway, Volume (Units) by Segment, Historic, 2004-2011 135
Table 68: Cardiovascular Surgery, Norway, Volume (Units) by Segment, Forecast, 2011-2018 137
Table 69: Beating Heart Surgery Systems, Norway, Volume (Units) by Sub-Segment, Historic,
2004-2011 139
Table 70: Beating Heart Surgery Systems, Norway, Volume (Units) by Sub-Segment, Forecast,
2011-2018 141
Table 71: Perfusion Disposables, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011
143
Table 72: Perfusion Disposables, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
144
Table 73: Cardiovascular Surgery, Norway, Average Price ($), Historic, 2004-2011 145
Table 74: Cardiovascular Surgery, Norway, Average Price ($), Forecast, 2011-2018 145
Table 75: Cardiovascular Surgery, Norway, Distribution Share by Revenue ($m), USD Constant,
2010-2011 146
Table 76: Cardiovascular Surgery, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 148
Table 77: Electrophysiology, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 150
Table 78: Electrophysiology, Norway, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 152
Table 79: Electrophysiology Diagnostic Catheters, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 154
Table 80: Electrophysiology Diagnostic Catheters, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 156
Table 81: Electrophysiology Ablation Catheters, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 158
Table 82: Electrophysiology Ablation Catheters, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 160
Table 83: Electrophysiology, Norway, Volume (Units) by Segment, Historic, 2004-2011 162
Table 84: Electrophysiology, Norway, Volume (Units) by Segment, Forecast, 2011-2018 163
Table 85: Electrophysiology Diagnostic Catheters, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 165
Table 86: Electrophysiology Diagnostic Catheters, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 167
Table 87: Electrophysiology Ablation Catheters, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 169
Table 88: Electrophysiology Ablation Catheters, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 171
Table 89: Electrophysiology, Norway, Average Price ($), Historic, 2004-2011 172
Table 90: Electrophysiology, Norway, Average Price ($), Forecast, 2011-2018 172
Table 91: Electrophysiology, Norway, Distribution Share by Revenue ($m), USD Constant, 2010-

11. 2011 173
Table 92: Electrophysiology, Norway, Company Share by Revenue ($m), USD Constant, 2010-
2011 175
Table 93: External Defibrillators, Norway, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 177
Table 94: External Defibrillators, Norway, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 179
Table 95: External Defibrillators, Norway, Volume (Units) by Segment, Historic, 2004-2011 181
Table 96: External Defibrillators, Norway, Volume (Units) by Segment, Forecast, 2011-2018 183
Table 97: External Defibrillators, Norway, Average Price ($), Historic, 2004-2011 184
Table 98: External Defibrillators, Norway, Average Price ($), Forecast, 2011-2018 184
Table 99: External Defibrillators, Norway, Distribution Share by Revenue ($m), USD Constant,
2010-2011 185
Table 100: External Defibrillators, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 187
Table 101: Interventional Cardiology, Norway, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 189
Table 102: Interventional Cardiology, Norway, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 191
Table 103: Cardiac Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 193
Table 104: Cardiac Catheters, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 195
Table 105: Coronary Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 197
Table 106: Coronary Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 199
Table 107: PTCA Balloons, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 201
Table 108: PTCA Balloons, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 203
Table 109: Arteriotomy Closure Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 205
Table 110: Arteriotomy Closure Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 207
Table 111: Intravascular Ultrasound Systems (IVUS), Norway, Revenue ($m) USD Constant, by
Sub-Segment, Historic, 2004-2011 209
Table 112: Intravascular Ultrasound Systems (IVUS), Norway, Revenue ($m) USD Constant, by
Sub-Segment, Forecast, 2011-2018 211
Table 113: Interventional Cardiology, Norway, Volume (Units) by Segment, Historic, 2004-2011
213
Table 114: Interventional Cardiology, Norway, Volume (Units) by Segment, Forecast, 2011-2018

12. 215
Table 115: Cardiac Catheters, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 217
Table 116: Cardiac Catheters, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
218
Table 117: Coronary Stents, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 220
Table 118: Coronary Stents, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 221
Table 119: PTCA Balloons, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 223
Table 120: PTCA Balloons, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 225
Table 121: Arteriotomy Closure Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 227
Table 122: Arteriotomy Closure Devices, Norway, Volume (Units) by Sub-Segment, Forecast,
2011-2018 229
Table 123: Intravascular Ultrasound Systems (IVUS), Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 231
Table 124: Intravascular Ultrasound Systems (IVUS), Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 233
Table 125: Interventional Cardiology, Norway, Average Price ($), Historic, 2004-2011 234
Table 126: Interventional Cardiology, Norway, Average Price ($), Forecast, 2011-2018 235
Table 127: Interventional Cardiology, Norway, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 236
Table 128: Interventional Cardiology, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 238
Table 129: Peripheral Vascular Devices, Norway, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 240
Table 130: Peripheral Vascular Devices, Norway, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 242
Table 131: Stent Grafts, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 244
Table 132: Stent Grafts, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 246
Table 133: Inferior Vena Cava Filters (IVCF), Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 248
Table 134: Inferior Vena Cava Filters (IVCF), Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 250
Table 135: Peripheral Guidewires, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Historic, 2004-2011 252
Table 136: Peripheral Guidewires, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Forecast, 2011-2018 254
Table 137: Peripheral Vascular Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 256
Table 138: Peripheral Vascular Stents, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 258

13. Table 139: Peripheral Embolic Protection Devices, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 260
Table 140: Peripheral Embolic Protection Devices, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 262
Table 141: Peripheral Vascular Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011
264
Table 142: Peripheral Vascular Devices, Norway, Volume (Units) by Segment, Forecast, 2011-
2018 266
Table 143: Stent Grafts, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 268
Table 144: Stent Grafts, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 269
Table 145: Inferior Vena Cava Filters (IVCF), Norway, Volume (Units) by Sub-Segment, Historic,
2004-2011 271
Table 146: Inferior Vena Cava Filters (IVCF), Norway, Volume (Units) by Sub-Segment, Forecast,
2011-2018 273
Table 147: Peripheral Guidewires, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011
275
Table 148: Peripheral Guidewires, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
277
Table 149: Peripheral Vascular Stents, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 279
Table 150: Peripheral Vascular Stents, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 281
Table 151: Peripheral Embolic Protection Devices, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 283
Table 152: Peripheral Embolic Protection Devices, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 285
Table 153: Peripheral Vascular Devices, Norway, Average Price ($), Historic, 2004-2011 286
Table 154: Peripheral Vascular Devices, Norway, Average Price ($), Forecast, 2011-2018 287
Table 155: Peripheral Vascular Devices, Norway, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 288
Table 156: Peripheral Vascular Devices, Norway, Company Share by Revenue ($m), USD
Constant, 2010-2011 290
Table 157: Prosthetic Heart Valves, Norway, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 292
Table 158: Prosthetic Heart Valves, Norway, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 294
Table 159: Mechanical Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 296
Table 160: Mechanical Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 298
Table 161: Tissue Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 300

14. Table 162: Tissue Heart Valves, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 302
Table 163: Prosthetic Heart Valves, Norway, Volume (Units) by Segment, Historic, 2004-2011 303
Table 164: Prosthetic Heart Valves, Norway, Volume (Units) by Segment, Forecast, 2011-2018
304
Table 165: Mechanical Heart Valves, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 306
Table 166: Mechanical Heart Valves, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 308
Table 167: Tissue Heart Valves, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011
310
Table 168: Tissue Heart Valves, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
312
Table 169: Prosthetic Heart Valves, Norway, Average Price ($), Historic, 2004-2011 313
Table 170: Prosthetic Heart Valves, Norway, Average Price ($), Forecast, 2011-2018 313
Table 171: Prosthetic Heart Valves, Norway, Distribution Share by Revenue ($m), USD Constant,
2010-2011 314
Table 172: Prosthetic Heart Valves, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 316
1.2 List of Figures
Figure 1: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 20
Figure 2: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 22
Figure 3: Cardiovascular Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 24
Figure 4: Cardiovascular Devices, Norway, Company Share (%), 2011 26
Figure 5: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 28
Figure 6: Cardiac Assist Devices, Norway, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 30
Figure 7: Intra-Aortic Balloon Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 32
Figure 8: Intra-Aortic Balloon Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 34
Figure 9: Ventricular Assist Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 36
Figure 10: Ventricular Assist Devices, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 38
Figure 11: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Historic, 2004-2011 40
Figure 12: Cardiac Assist Devices, Norway, Volume (Units) by Segment, Forecast, 2011-2018 41
Figure 13: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-

15. 2011 42
Figure 14: Intra-Aortic Balloon Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 44
Figure 15: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Historic, 2004-
2011 46
Figure 16: Ventricular Assist Devices, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 48
Figure 17: Cardiac Assist Devices, Norway, Company Share (%), 2011 52
Figure 18: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 54
Figure 19: Cardiac Rhythm Management, Norway, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 56
Figure 20: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 58
Figure 21: Cardiac Resynchronisation Therapy, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 60
Figure 22: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 62
Figure 23: Implantable Cardioverter Defibrillators, Norway, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 64
Figure 24: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 66
Figure 25: Pacemakers, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 68
Figure 26: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Historic, 2004-
2011 70
Figure 27: Cardiac Rhythm Management, Norway, Volume (Units) by Segment, Forecast, 2011-
2018 72
Figure 28: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 74
Figure 29: Cardiac Resynchronisation Therapy, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 76
Figure 30: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,
Historic, 2004-2011 78
Figure 31: Implantable Cardioverter Defibrillators, Norway, Volume (Units) by Sub-Segment,
Forecast, 2011-2018 80
Figure 32: Pacemakers, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 82
Figure 33: Pacemakers, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 84
Figure 34: Cardiac Rhythm Management, Norway, Company Share (%), 2011 88
Figure 35: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m) USD
Constant, by Segment, Historic, 2004-2011 90
Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Norway, Revenue ($m) USD

16. Constant, by Segment, Forecast, 2011-2018 92
Figure 37: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) by
Segment, Historic, 2004-2011 94
Figure 38: Cardiovascular Monitoring and Diagnostic Devices, Norway, Volume (Units) by
Segment, Forecast, 2011-2018 96
Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Norway, Com
Contact: sales@reportsandreports.com for more information.